RNS Number : 4443L

Omega Diagnostics Group PLC

13 May 2022


("Omega" or the "Company" or the "Group")

Posting of Circular and Notice of General Meeting

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, announces, further to the announcement of 6 May 2022, a Circular containing details of the Open Offer and convening the General Meeting, together with a Form of Proxy will be posted to Shareholders today.

The General Meeting will be held at the offices of Shepherd & Wedderburn, 1 Exchange Crescent, Conference Square, Edinburgh, EH3 8UL at 11.00 a.m. on 6 June 2022. A copy of the Circular will today be made available on the Company's website: http://www.omegadiagnostics.com/Investor-Relations/Corporate-Information

Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's announcement dated 6 May 2022.


 Omega Diagnostics Group PLC                                  www.omegadx.com 
 Jag Grewal, Chief Executive                                  via Walbrook PR 
 Chris Lea, Chief Financial 
 finnCap Ltd                                               Tel: 020 7220 0500 
 Geoff Nash/Edward Whiley/George Dollemore 
  (Corporate Finance) 
 Alice Lane/ Harriet Ward 
 Walbrook PR Limited               Tel: 020 7933 8780 or omega@walbrookpr.com 
 Paul McManus                                              Mob: 07980 541 893 
 Lianne Applegarth                                         Mob: 07584 391 303 
 Sam Allen                                                 Mob: 07502 558 258 

About Omega Diagnostics Group PLC

Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

May 13, 2022 05:05 ET (09:05 GMT)

Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Omega Diagnostics Charts.
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Omega Diagnostics Charts.